SCHEMBL29467441

SCHEMBL29467441

COc1ncc(-c2cc([C@H]3C[C@@H]3C(C)C)c(C#N)nn2)c(OC)n1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.36
MDM2 Q00987 17/20 0.34
TP53 P04637 13/20 0.34
QPCT Q16769 1/20 0.32
QPCTL Q9NXS2 1/20 0.32
PIK3CD O00329 1/20 0.31
ABL1 P00519 1/20 0.31
EGFR P00533 1/20 0.31
HCK P08631 1/20 0.31
SRC P12931 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
MTOR P42345 1/20 0.31
PIK3CG P48736 1/20 0.31
EPHB4 P54760 1/20 0.31
PRKDC P78527 1/20 0.31
PI4KB Q9UBF8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28728598 1.00 NT5E (0.36) NT5EMDM2TP53QPCTQPCTL
SCHEMBL28728563 0.92 NT5E (0.36) NT5EMDM2TP53QPCTQPCTL
SCHEMBL29639797 0.90 NT5E (0.35) NT5EMDM2TP53QPCTQPCTL
SCHEMBL24418244 0.90 NT5E (0.35) NT5EMDM2TP53QPCTQPCTL
SCHEMBL25840630 0.88 QPCT (0.34) MDM2TP53QPCTQPCTLMTOR
SCHEMBL29614342 0.88 NT5E (0.39) NT5EMDM2TP53QPCTQPCTL
SCHEMBL24514847 0.88 NT5E (0.39) NT5EMDM2TP53QPCTQPCTL
SCHEMBL24300262 0.87 PPARD (0.33) MDM2TP53QPCTQPCTLMTOR
SCHEMBL22869335 0.86 NT5E (0.49) NT5EMDM2TP53QPCTQPCTL
SCHEMBL22869348 0.86 NT5E (0.49) NT5EMDM2TP53QPCTQPCTL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315839-A Pyrimidinedione compounds and use thereof 武汉人福创新药物研发中心有限公司 2022-04-12 CN disclosed
WO-2022068929-A1 PYRIMIDINEDIONE COMPOUND AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-04-07 WO disclosed